Sanam Loghavi, Associate Professor of Pathology at MD Anderson Cancer Center, Medical Director of ECOG-ACRIN Leukemia Bank and Editor in Chief of Image Bank at the American Society of Hematology, shared a post on X:
“The PRISM AML risk model for HMA+VEN is now out in JCO ASCO Congratulations to Curtis Lachowiez and all investigators on this huge accomplishment addressing a much needed clinical gap. We think it’s the Rolls-Royce Phantom of risk models!!!
Bonus: IT HAS A CALCULATOR Try it out …. you will love it.”
Title: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model
Authors: Curtis A. Lachowiez, Joshua F. Zeidner, Jad Othman, Andy Kaempf, Seongseok Yun, Maël Heiblig, Michael Heuser, Rabia Shahswar, Rafael Madero Marroquin, Joseph M. Cannova, Andrius Žučenka, Jennifer Marvin-Peek, Jayastu Senapati, Yasmin Abaza, Alok Swaroop, Irene Zacheo, Federica Monaco, Amine Belhabri, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Martin Carré, Gaspar Aspas Requena, Rachel J. Cook, Elie Traer, Jennifer N. Saultz, Jenny O’Nions, Faisal Basheer, John Laurie, Shivani Handa, Eytan M. Stein, Maria R. Baer, Rebecca Olin, William Blum, Gary Schiller, Tara Lin, Emily Curran, Ashley Yocum, Ellen Madarang, Naval Daver, Tapan M. Kadia, Giovanni Marconi, Yazan Madanat, Richard Dillon, Courtney D. DiNardo, Ronan Swords, Juan E. Arango Ossa, Justin Watts, Sanam Loghavi, Daniel A. Pollyea, Elsa Bernard
Read the full article on JCO ASCO.
Other Articles Featuring Sanam Loghavi on OncoDaily.
